MacroGenics
MGNX
#8794
Rank
HK$1.86 B
Marketcap
HK$29.35
Share price
5.35%
Change (1 day)
115.50%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): -HK$4.49

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -HK$4.47. In 2025 the company made an earnings per share (EPS) of -HK$9.26 a decrease over its 2024 EPS that were of -HK$8.40.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$4.49-51.53%
2025-HK$9.2610.28%
2024-HK$8.40613.33%
2023-HK$1.18-92.31%
2022-HK$15.30-42.14%
2021-HK$26.4536.44%
2020-HK$19.38-21.84%
2019-HK$24.80-24.58%
2018-HK$32.88675.93%
2017-HK$4.24-68.05%
2016-HK$13.26168.25%
2015-HK$4.94-55%
2014-HK$10.993400%
2013-HK$0.31-108.68%
2012HK$3.6224.49%
2011HK$2.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.96-233.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$234.50-5,342.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$127.28-2,945.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-HK$20.40 356.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$9.93-322.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.63-896.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-HK$17.03 280.70%๐Ÿ‡บ๐Ÿ‡ธ USA